In prostate cancer, diagnostic models combining Prostate Imaging Reporting and Data System scores from multiparametric MRI with serum prostate-specific antigen levels have been shown to improve diagnostic accuracy compared to models using either modality alone [19,20]. This evidence concerns the gene KLK3 and prostate carcinoma.